tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market
HKMPY
Hikma Pharmaceuticals
RESEARCH TOOLSreports
Advertisement

Hikma Pharmaceuticals (HKMPY) Stock News & Sentiment

Compare
44 Followers
Hikma Pharma’s Study on Generic Imatinib: A Potential Game Changer in Leukemia Treatment
Premium
Company Announcements
Hikma Pharma’s Study on Generic Imatinib: A Potential Game Changer in Leukemia Treatment
12d ago
HKMPY
Hikma Pharma’s New AML Study: A Potential Game-Changer for Investors
Premium
Company Announcements
Hikma Pharma’s New AML Study: A Potential Game-Changer for Investors
12d ago
HKMPY
Promising Financial Outlook and Strategic Positioning of Hikma Pharmaceuticals: A Buy Recommendation by Christian Glennie
Premium
Ratings
Promising Financial Outlook and Strategic Positioning of Hikma Pharmaceuticals: A Buy Recommendation by Christian Glennie
7M ago
Hikma Pharmaceuticals: Strategic Growth and Resilience Amid Market Opportunities
Premium
Ratings
Hikma Pharmaceuticals: Strategic Growth and Resilience Amid Market Opportunities
7M ago
Hikma Pharmaceuticals: Strong Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Hikma Pharmaceuticals: Strong Performance and Growth Potential Justify Buy Rating
8M ago
Hikma Pharmaceuticals: Strong FY24 Performance and Promising FY25 Outlook Justify Buy Rating
Premium
Ratings
Hikma Pharmaceuticals: Strong FY24 Performance and Promising FY25 Outlook Justify Buy Rating
9M ago
Hikma Pharmaceuticals (HKMPY) Declares Q3 Dividend: Important Details for Shareholders
Premium
Dividends
Hikma Pharmaceuticals (HKMPY) Declares Q3 Dividend: Important Details for Shareholders
1y ago
HKMPY
More HKMPY News >

HKMPY News on the Web

Peel Hunt Keeps Their Buy Rating on Hikma Pharmaceuticals (HIK)
TipRanks News
Neutral
Hikma Pharmaceuticals (HIK) Receives a Buy from Jefferies
TipRanks News
Neutral
Hikma Pharmaceuticals Acquires FDA-Approved ANDA for Trametinib Tablets | HKMPY stock news
GuruFocus News
Bullish
Hikma acquires Novugen's FDA-approved ANDA for trametinib | HKMPY Stock News
GuruFocus News
Neutral
AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals
Yahoo Finance
Neutral
Hikma Pharmaceuticals PLC Earnings Call Highlights: Surpassing Revenue ...
Yahoo Finance
Neutral
Trending tickers: Nvidia, Tesla, Super Micro, AB InBev and BP
Yahoo Finance UK
Neutral
Stocks to watch next week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin
Yahoo Finance UK
Neutral

News Score - Last 7 Days

Neutral
HKMPY
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HKMPY’s Media Buzz Sentiment?
2 articles about HKMPY were published this week. In an average week, 1 articles are published.
    What is HKMPY’s weekly average amount of articles?
    In an average week, 1 articles about HKMPY are published.
      What is HKMPY’s News Sentiment?
      50% of articles about HKMPY were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        LSTALisata Therapeutics
        ACADACADIA Pharmaceuticals
        ALKSAlkermes
        IDXXIdexx Laboratories
        STESteris
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing